158 related articles for article (PubMed ID: 16751382)
21. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.
Sauzet JP; Gras-Masse H; Guillet JG; Gomard E
Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632
[TBL] [Abstract][Full Text] [Related]
22. Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.
Ottenhoff TH; Mutis T
J Exp Med; 1990 Jun; 171(6):2011-24. PubMed ID: 1972178
[TBL] [Abstract][Full Text] [Related]
23. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
24. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease.
Richards DM; Dalheimer SL; Ehst BD; Vanasek TL; Jenkins MK; Hertz MI; Mueller DL
J Immunol; 2004 Mar; 172(6):3469-79. PubMed ID: 15004147
[TBL] [Abstract][Full Text] [Related]
25. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.
Hermans IF; Ritchie DS; Yang J; Roberts JM; Ronchese F
J Immunol; 2000 Mar; 164(6):3095-101. PubMed ID: 10706699
[TBL] [Abstract][Full Text] [Related]
26. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.
Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Berzofsky JA
J Immunol; 2007 Jun; 178(11):7211-21. PubMed ID: 17513770
[TBL] [Abstract][Full Text] [Related]
27. Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus.
Jones CM; Cose SC; McNally JM; Jennings SR; Heath WR; Carbone FR
J Gen Virol; 2000 Feb; 81(Pt 2):407-14. PubMed ID: 10644839
[TBL] [Abstract][Full Text] [Related]
28. Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance.
den Boer AT; Diehl L; van Mierlo GJ; van der Voort EI; Fransen MF; Krimpenfort P; Melief CJ; Offringa R; Toes RE
J Immunol; 2001 Sep; 167(5):2522-8. PubMed ID: 11509591
[TBL] [Abstract][Full Text] [Related]
29. A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells.
Blanas E; Davey GM; Carbone FR; Heath WR
J Immunol; 2000 Mar; 164(6):2890-6. PubMed ID: 10706674
[TBL] [Abstract][Full Text] [Related]
30. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.
Xiang J; Huang H; Liu Y
J Immunol; 2005 Jun; 174(12):7497-505. PubMed ID: 15944248
[TBL] [Abstract][Full Text] [Related]
31. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
[TBL] [Abstract][Full Text] [Related]
32. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
34. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.
Cooper LJ; Al-Kadhimi Z; Serrano LM; Pfeiffer T; Olivares S; Castro A; Chang WC; Gonzalez S; Smith D; Forman SJ; Jensen MC
Blood; 2005 Feb; 105(4):1622-31. PubMed ID: 15507526
[TBL] [Abstract][Full Text] [Related]
35. Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.
Marzo AL; Kinnear BF; Lake RA; Frelinger JJ; Collins EJ; Robinson BW; Scott B
J Immunol; 2000 Dec; 165(11):6047-55. PubMed ID: 11086036
[TBL] [Abstract][Full Text] [Related]
36. Cross-presentation of tumor antigens to effector T cells is sufficient to mediate effective immunotherapy of established intracranial tumors.
Plautz GE; Mukai S; Cohen PA; Shu S
J Immunol; 2000 Oct; 165(7):3656-62. PubMed ID: 11034369
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection.
Jones CM; Cose SC; Coles RM; Winterhalter AC; Brooks AG; Heath WR; Carbone FR
J Virol; 2000 Mar; 74(5):2414-9. PubMed ID: 10666272
[TBL] [Abstract][Full Text] [Related]
38. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
Babu JS; Nair S; Kanda P; Rouse BT
Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518
[TBL] [Abstract][Full Text] [Related]
39. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
40. B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen.
Sun Q; Burton RL; Dai LJ; Britt WJ; Lucas KG
J Immunol; 2000 Oct; 165(7):4105-11. PubMed ID: 11034422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
